ClinicalTrials.gov
public full text
Public Domain
Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma
RATIONALE: Thalidomide may kill cancer cells by stopping the growth of new blood vessels to the tumor. PURPOSE: Phase II trial to study the effectiveness of thalidomide in treating patients with HIV-associated Kaposi's sarcoma.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma#825405
- Daclizumab to Treat HIV-Infected Patients#830283
- Kaposi Sarcoma Chemotherapy and Research (KS-CARE)#897976
- Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma#1162470
- Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected People#1172055
Record · ID 877132
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive